News

Drug giant Pfizer isn’t ready to abandon neuroscience — here’s its $150-million ‘star cluster’ strategy for betting on promising brain drug startups

Last year, after several failures related to Alzheimer’s disease drugs, pharmaceutical giant Pfizer announced it was stepping away from neuroscience research and development. The company isn’t completely done with the field. It partnered with Bain Capital in October to launch neuroscience spinoff Cerevel Therapeutics. Cerevel is part of a much […]
Drug giant Pfizer isn’t ready to abandon neuroscience — here’s its $150-million ‘star cluster’ strategy for betting on promising brain drug startups
News

A revolutionary drug that could treat a rare and devastating disease is prohibitively expensive. But one state has a plan to pay for its potential $5 million price tag.

A one-time treatment for a devastating rare disease could be paid for with an instalment plan as soon as this summer in Massachusetts. Novartis’s AveXis unit is involved in the discussions. Its gene therapy could cost up to $US5 million per treatment. Organisers hope the plan will ensure patients can […]
A revolutionary drug that could treat a rare and devastating disease is prohibitively expensive. But one state has a plan to pay for its potential $5 million price tag.
News

Dispensed: What we saw at JPMorgan’s big healthcare investor conference

Hello, It’s been a long, exciting albeit tiring week for the healthcare team as we made our way around San Francisco’s Union Square during the J.P. Morgan Healthcare Conference. Hills were climbed, cricket tacos consumed, and healthcare discussed at length. Many, many stories ahead from those conversations. But to start, […]
Dispensed: What we saw at JPMorgan’s big healthcare investor conference
News

A Silicon Valley startup that pioneered a new way to fight diabetes is tackling depression after its CEO noticed a disturbing trend

Silicon Valley digital health startup Omada told Business Insider that it’s expanding beyond treating obesity-related diseases like diabetes into depression and anxiety. The move, which was officially announced on Monday, includes a partnership with the mental-health startup Lantern to offer customers cognitive behavioural therapy (CBT). Omada has prominent backers, including […]
A Silicon Valley startup that pioneered a new way to fight diabetes is tackling depression after its CEO noticed a disturbing trend